K. Varani et al., BINDING CHARACTERISTICS OF THE ADENOSINE-A(2) RECEPTOR-LIGAND [H-3] CGS-21680 TO HUMAN PLATELET MEMBRANES, Biochemical pharmacology, 48(8), 1994, pp. 1658-1661
The binding characteristics of the selective adenosine A(2) agonist [H
-3]CGS 21680 )-phenethyl-amino]-5'-N-ethylcarboxamidoadenosine) were d
etermined in human platelet membranes. Specific binding was saturable,
reversible and dependent upon protein concentration. Saturation exper
iments revealed a single class of binding sites with K-d and B-max val
ues of 1.4 mu M and 5.9 pmol/mg of protein, respectively. Adenosine re
ceptor agonists and antagonists competed for the binding of [H-3]CGS 2
1680 (50 or 200 nM) to human platelet membranes showing a rank order o
f potency consistent with that typically found for interactions at the
adenosine Al receptor. Adenylate cyclase stimulation and platelet agg
regation inhibition induced by adenosine agonists exhibited a rank ord
er of potency close to that observed in binding experiments. However,
the adenosine A(1) receptor agonists, R- and S-N-6-(2-phenylisopropyl)
adenosine, (R-PIA) and (S-PIA), N-6-cyclohexyladenosine (CHA) and 2-ch
loro-N-6-cyclopentyladenosine (CCPA), which stimulate adenylate cyclas
e and inhibit platelet aggregation in the low mu M range, displaced [H
-3]CGS 21680 only in the high mu M range. In conclusion, we have found
that [3H]CGS 21680, which is widely used as a specific A(2) agonist i
n binding studies on brain tissues, is not appropriate for the charact
erization of the human platelet adenosine Az receptor.